Evotec Investor Day Presentation Deck

evotec Global pharmaceutical R&D market¹), 2) in US$ bn Cell & Gene Tx Biologics Small molecules PAGE 11 670 Multimodality is reality Small molecules, biologics & other modalities 2017 703 2018 743 2019 +7% ¹) Small molecules forecast from May 2017 and Biologics forecast from Dec 2017 2) Excluding sales not classified by EvaluatePharma Source: EvaluatePharma; Evotec estimates 794 2020e 856 2021e 918 2022e CAGR 2017-22e >50% 8% 5%

View entire presentation